(Q42432919)

English

Expression of 'drugable' tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancer

scientific article published on July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

Expression of 'drugable' tyrosine kinase receptors in malignant peripheral nerve sheath tumour: potential molecular therapeutic targets for a chemoresistant cancer (English)

1 reference

Europe PubMed Central

31 October 2017

Alexander J. Lazar

7

1 reference

Europe PubMed Central

31 October 2017

object named as

Kai-Lieh Huang

4

0 references

object named as

Eric Young

3

0 references

author name string

Keila E Torres

1

1 reference

Europe PubMed Central

31 October 2017

Jun Liu

2

1 reference

Europe PubMed Central

31 October 2017

Markus Ghadimi

5

1 reference

Europe PubMed Central

31 October 2017

Kristelle Lusby

6

1 reference

Europe PubMed Central

31 October 2017

Dina Lev

8

1 reference

Europe PubMed Central

31 October 2017

publication date

1 July 2011

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

59

1 reference

Europe PubMed Central

31 October 2017

1

1 reference

Europe PubMed Central

31 October 2017

156-159

1 reference

Europe PubMed Central

31 October 2017

Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532392

28 May 2018

Dual targeting of AKT and mammalian target of rapamycin: a potential therapeutic approach for malignant peripheral nerve sheath tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532392

28 May 2018

EGFR and erbB2 in malignant peripheral nerve sheath tumors and implications for targeted therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532392

28 May 2018

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532392

28 May 2018

Tyrosine kinases as targets in cancer therapy - successes and failures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532392

28 May 2018

The emergence of resistance to targeted cancer therapeutics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4532392

28 May 2018

Clinical, Pathological, and Molecular Variables Predictive of Malignant Peripheral Nerve Sheath Tumor Outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.03867.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2011.03867.X

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42432919&oldid=1571881452"